Long-Acting Injectable Antipsychotics: Enhancing Treatment Compliance

This chapter explores the benefits of long-acting injectable antipsychotics (LAIs) for patients with schizophrenia, focusing on improved medication adherence and significant reductions in relapse and mortality rates. The discussion includes practical aspects of administration, comparisons to oral medications, and the importance of monitoring post-injection effects. Through analysis of studies and clinical experiences, the chapter emphasizes the robust impact that LAIs can have on patient outcomes and overall treatment effectiveness.